Ahmed Hamdy
Chief Executive Officer at VINCERX PHARMA, INC.
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pablo D. T. Valenzuela | M | - |
Andes Biotechnologies Global, Inc.
 Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA.
Andes Biotechnologies SA
 Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 16 years |
| Raquel Izumi | M | 54 | 8 years | |
| Jeffrey Pott | M | - | 29 years | |
| Marc Dunoyer | M | 71 | 11 years | |
| Luis O. Burzio | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 16 years |
| Laura Bushnell | F | 56 |
Baskin School of Engineering
| 5 years |
| Michel Demaré | M | 67 | 5 years | |
| Shu Kam Mok | M | 63 | 5 years | |
| Richard Slavin | M | - |
The Palo Alto Medical Foundation
| - |
| Sherilyn McCoy | F | 65 | 7 years | |
| Alexander Seelenberger Farba | M | 45 |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 15 years |
| Pascal Soriot | M | 64 | 12 years | |
| Ruth Stevens | M | 64 | 3 years | |
| Pam Cheng | F | 53 | 9 years | |
| Francisco Salva | M | 53 | 4 years | |
| Aradhana Sarin | M | 50 | 3 years | |
| Nazneen Rahman | M | - | 7 years | |
| Patricio Cáceres | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| Deborah DiSanzo | F | 64 | 7 years | |
| Cristian Hernández-Cuevas | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| John Lee | M | 56 | 4 years | |
| Tasheda Navarro | F | - | 3 years | |
| Tom Thomas | M | 64 | 6 years | |
| Philip Broadley | M | 63 | 7 years | |
| Marcus Wallenberg | M | 68 | 25 years | |
| Soo In Hwang | M | 64 | 6 years | |
| Brian Druker | M | 68 | 4 years | |
| Dominique Quincy | M | - |
The Palo Alto Medical Foundation
| - |
| Jonathan Thomas Charles Slade | M | 59 | - | |
| Bill Donaldson | M | - | - | |
| Jennifer Taubert | F | 60 | 19 years | |
| Sjoerd Hubben | M | - | 8 years | |
| Regina Danielson | M | 60 | - | |
| David Fredrickson | M | - | 7 years | |
| Helen MacPhee | F | 64 | - | |
| Josie Afolabi | F | - | 14 years | |
| Elizabeth Forminard | F | 53 | 18 years | |
| Cindy Hoots | F | 56 | 4 years | |
| Alberto Hegewisch | M | - | 1 years | |
| Iskra Reic | F | - | 23 years | |
| Ruud Dobber | M | - | 27 years | |
| Tyrell J. Rivers | M | 51 | 10 years | |
| Margaret A. Taylor | F | - |
The Palo Alto Medical Foundation
| - |
| Robert Jaunich | M | 84 |
The Palo Alto Medical Foundation
| - |
| Elizabeth Dávila | F | 80 |
The Palo Alto Medical Foundation
| - |
| Dan Maydan | M | 88 |
The Palo Alto Medical Foundation
| 21 years |
| Sanjay Subhedar | M | - |
The Palo Alto Medical Foundation
| - |
| Kevin Lokay | M | 67 | 6 years | |
| Susan B. Ford-Dorsey | F | 69 |
The Palo Alto Medical Foundation
| - |
| Andreas Rummelt | M | 66 | 3 years | |
| Elizabeth Vilardo | M | - |
The Palo Alto Medical Foundation
| 9 years |
| Adrian Charles Noel Kemp | M | 58 | 15 years | |
| Susan Ford Dorsey | F | - |
The Palo Alto Medical Foundation
| - |
| Bob S. Hu | M | - |
The Palo Alto Medical Foundation
| - |
| Martin Entwistle | M | - |
The Palo Alto Medical Foundation
| - |
| Paul Tang | M | - |
The Palo Alto Medical Foundation
| - |
| Elsa Johnson | F | - | - | |
| Bernardita Méndez Velasco | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| Diana Layfield | F | - | 4 years | |
| Susan Mary Galbraith | M | - | 14 years | |
| Margareta Elisabeth Björk | M | 63 | 22 years | |
| Anna Olive Magdelene Manz | F | 51 | 1 years | |
| Euan Ashley | M | - | 4 years | |
| Sharon Barr | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Miller | M | 73 | 17 years | |
| Simon Lowth | M | 62 | 6 years | |
| Robert Duggan | M | 79 | 7 years | |
| Ramses Erdtmann | M | 60 | 6 years | |
| Leif Valdemar Johansson | M | 73 | 11 years | |
| Joseph Papa | M | 68 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 3 years |
| Leiv Lea | M | 70 | 11 years | |
| Mahkam Zanganeh | M | 52 | 7 years | |
| Eric Hedrick | M | 59 | 2 years | |
| Joseph Peter | M | 60 | - | |
| Lisa Romanko | F | - | 19 years | |
| Jacques Dumas | M | 58 | 7 years | |
| Carla Sivak | F | - | 4 years | |
| Menelas Pangalos | M | 57 | 13 years | |
| Shriti Vadera | F | 62 | 7 years | |
| David Smith | M | - | 9 years | |
| Minesh P. Mehta | M | 65 | - | |
| Donald Bruce Burlington | M | 75 | 7 years | |
| Glenn C. Rice | M | 68 | 2 years | |
| Briggs Morrison | M | 65 | 3 years | |
| José Baselga | M | 65 | 2 years | |
| Geneviéve B. Berger | M | 69 | 9 years | |
| David Duane Smith | M | 52 | - | |
| Jean-Philippe Courtois | M | 63 | 8 years | |
| Nancy Rothwell | M | 68 | 9 years | |
| Christopher Lowe | M | 56 | 2 years | |
| James A. Nash | M | 73 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | - |
| Graham Chipchase | M | 61 | 9 years | |
| James N. Lowder | M | 74 | - | |
| Charles O. Prince | M | 74 | 17 years | |
| John Varley | M | 67 | 9 years | |
| Jack Michelson | M | 89 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 11 years |
| Rudolph Markham | M | 78 | 11 years | |
| Catherine Klema | F | 65 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 9 years |
| Michael Johns | M | 82 | 9 years | |
| Michael Zinda | M | 53 | 16 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 49 | 49.00% |
| United States | 47 | 47.00% |
| Chile | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ahmed Hamdy
- Personal Network
